TY  - JOUR
EP  - 139
JF  - Cell-Based Assays Using iPSCs for Drug Development and Testing
AV  - public
N2  - Induced pluripotent stem cells have great potential as a human model system in regenerative medicine,
disease modelling and drug screening. However, extensive analysis of iPSC are required before their
therapeutic applications. With recent developments in mass spectrometry and proteomics, this
technique can become a great alternative to traditional genomic approaches for iPSC analysis. Here, we
describe preparation of iPSC for targeted proteomic analysis, and measurement of pluripotency markers
allowing for classification into either pluripotent or non-pluripotent cells.
VL  - 1994
UR  - https://doi.org/10.1007/978-1-4939-9477-9_11
A1  - Baud, A
A1  - Heywood, WE
A1  - Little, D
A1  - Gissen, P
A1  - Mills, K
KW  - Induced pluripotent stem cells
KW  -  pluripotency
KW  -  proteomics
KW  -  mass spectrometry
ID  - discovery10080976
N1  - This version is the author accepted manuscript. For information on re-use, please refer to the publisher?s terms and conditions.
SP  - 131
Y1  - 2019///
SN  - 1940-6029
TI  - Preparation of iPSCs for Targeted Proteomic Analysis
ER  -